IL1B, P2RX7, IFNB1, IFNB1, TNF, and CASP1 enhance the network connectivity between multiple sclerosis (MS) complex genomes associated with COVID-19 and NOD-like receptor (NLR) signaling. Here, IFNB1 is linked to myeloid sarcoma.